Journal of the American Chemical Society
Page 8 of 8
1
2
3
4
5
6
7
8
lan, D. W. C. Nat. Chem. (advance online publication)
doi:10.1038/nchem.2825
hydroxycyclotryptamine is also isolated in 36% yield after
work-up.
(13) For related discussions, see: (a) Kosower, E. M. Acc. Chem.
Res. 1971, 4, 193. (b) Tsuji, T.; Kosower, E. M. J. Am. Chem. Soc.
1971, 93, 1992. (c) Corey, E. J.; Cane, D. E.; Libit, L. J. Am. Chem. Soc.
1971, 93, 7016. (d) Myers, A. G.; Kukkola, P. J. J. Am. Chem. Soc.
1990, 112, 8208. (e) Guziec, Jr., F. S.; Wei, D. J. Org. Chem. 1992, 57,
3772. (f) Myers, A. G.; Zheng, B. J. Am. Chem. Soc. 1996, 118, 4492.
(14) Hoffmann, S.; Seayad, A. M.; List, B. Angew. Chem., Int. Ed.
2005, 44, 7424.
(15) See Supporting Information for details.
(16) Roizen, J. L.; Zalatan, D. N.; Du Bois, J. Angew. Chem., Int.
Ed. 2013, 52, 11343.
(17) For selected reviews on C–H amination, see: (a) Collet, F.;
Dodd, R. H.; Dauban, P. Chem. Commun. 2009, 5061. (b) Shin, K.;
Kim, H.; Chang, S. Acc. Chem. Res. 2015, 48, 1040. (c) Kim, H.;
Chang, S. ACS Catal. 2016, 6, 234.
(18) Xu, L.; Tan, L.; Ma, D. J. Org. Chem. 2016, 81, 10476.
(19) Anet, E. F. L. J.; Hughes, G. K.; Ritchie, E. Aust. J. Chem.
1961, 14, 173.
(3) (a) Kim, J.; Movassaghi, M. J. Am. Chem. Soc. 2011, 133,
14940. (b) Boyer, N.; Movassaghi, M. Chem. Sci. 2012, 3, 1798. (c)
Coste, A.; Kim, J.; Adams, T. C.; Movassaghi, M. Chem. Sci. 2013, 4,
3191. (d) Loach, R. P.; Fenton, O. S.; Movassaghi, M. J. Am. Chem.
Soc. 2016, 138, 1057.
(4) For representative syntheses, see: (a) Hendrickson, J. B.; Rees,
R.; Göschke, R. Proc. Chem. Soc. 1962, 383. (b) Hino, T.; Yamada, S.-
I. Tetrahedron Lett. 1963, 4, 1757. (c) Hendrickson, J. B.; Göschke, R.;
Rees, R. Tetrahedron 1964, 20, 565. (d) Scott, A. I.; McCapra, F.; Hall,
E. S. J. Am. Chem. Soc. 1964, 86, 302. (e) Hall, E. S.; McCapra, F.;
Scott, A. J. Tetrahedron 1967, 23, 4131. (f) Hino, T.; Kodato, S.;
Takahashi, K.; Yamaguchi, H.; Nakagawa, M. Tetrahedron Lett. 1978,
19, 4913. (g) Nakagawa, M.; Sugumi, H.; Kodato, S.; Hino, T. Tetrahe-
dron Lett. 1981, 22, 5323. (h) Fang, C.-L.; Horne, S.; Taylor, N.; Rodri-
go, R. J. Am. Chem. Soc. 1994, 116, 9480. (i) Link, J. T.; Overman, L.
E. J. Am. Chem. Soc. 1996, 118, 8166. (j) Somei, M.; Oshikiri, N.; Ha-
segawa, M.; Yamada, F. Heterocycles 1999, 51, 1237. (k) Overman, L.
E.; Paone, D. V.; Stearns, B. A. J. Am. Chem. Soc. 1999, 121, 7702. (l)
Overman, L. E.; Larrow, J. F.; Stearns, B. A.; Vance, J. M. Angew.
Chem., Int. Ed. 2000, 39, 213. (m) Verotta, L.; Orsini, F.; Sbacchi, M.;
Scheildler, M. A.; Amador, T. A.; Elisabetsky, E. Bioorg. Med. Chem.
2002, 10, 2133. (n) Ishikawa, H.; Takayama, H.; Aimi, N. Tetrahedron
Lett. 2002, 43, 5637. (o) Matsuda, Y.; Kitajima, M.; Takayama, H.
Heterocycles 2005, 65, 1031. (p) Tadano, S.; Mukaeda, Y.; Ishidawa, H.
Angew. Chem., Int. Ed. 2013, 52, 7990.
(5) (a) Movassaghi, M.; Schmidt, M. A. Angew. Chem., Int. Ed.
2007, 46, 3725. (b) Kim, J.; Ashenhurst, J. A.; Movassaghi, M. Science
2009, 324, 238. (c) Kim, J.; Movassaghi, M. J. Am. Chem. Soc. 2010,
132, 14376.
(6) (a) Movassaghi, M.; Ahmad, O. K.; Lathrop, S. P. J. Am. Chem.
Soc. 2011, 133, 13002; (b) Lathrop, S. P.; Movassaghi, M. Chem. Sci.
2014, 5, 333; (c) Lathrop, S. P.; Pompeo, M.; Chang, W.-T. T.; Movas-
saghi, M. J. Am. Chem. Soc. 2016, 138, 7763.
(7) For other applications of the Co-promoted cyclotryptamine di-
merization chemistry, see: (a) Perez-Balado, C.; de Lera, A. R. Org.
Lett. 2008, 10, 3701. (b) Perez-Balado, C.; Rodríguez-Graña, P.; de
Lera, A. R. Chem.–Eur. J. 2009, 15, 9928. (c) Iwasa, E.; Hamashima,
Y.; Fujishiro, S.; Higuchi, E.; Ito, A.; Yoshida, M.; Sodeoka, M. J. Am.
Chem. Soc. 2010, 132, 4078. (d) Foo, K.; Newhouse, T.; Mori, I.; Taka-
yama, H.; Baran, P. S. Angew. Chem., Int. Ed. 2011, 50, 2716. (e) Xie,
X.; Jiang, G.; Liu, H.; Hu, J.; Pan, X.; Zhang, H.; Wan, X.; Lai, Y.; Ma,
D. Angew. Chem., Int. Ed. 2013, 52, 12924.
(8) For other C3a-aryldiazene synthesis methodologies, see: (a)
Stephens, D. E.; Larionov, O. V. Eur. J. Org. Chem. 2014, 3662. (b)
Nelson, H. M.; Reisberg, S. H.; Shunatona, H. P.; Patel, J. S.; Toste, F.
D. Angew. Chem., Int. Ed. 2014, 53, 5600.
(9) (a) Beretz, A.; Roth-Georger, A.; Corre, G.; Kuballa, B.; Anton,
R.; Cazenave, J.-P. Planta Med. 1985, 51, 300. (b) Adjibadé, Y.; Saad,
H.; Kuballa, B.; Beck, J. P.; Sévenet, T.; Cabalion, P.; Anton, R. J.
Ethnopharmacol. 1990, 29, 127. (c) Saad, H.-E. A.; El-Sharkawy, S. H.;
Shier, W. T. Planta Med. 1995, 61, 313. (d) Rasolonjanahary, R.; Sé-
venet, T.; Voegelein, F. G.; Kordon, C. Eur. J. Pharmacol. 1995, 285,
19. (e) Jannic, V.; Guéritte, F.; Laprévote, O.; Serani, L.; Martin, M.-T.;
Sévenet, T.; Potier, P. J. Nat. Prod. 1999, 62, 838. (f) Amador, T. A.;
Verotta, L.; Nunes, D. S.; Elisabetsky, E. Planta Med. 2000, 66, 770. (g)
Nascimento, R. R. G.; Pimenta, A. T. A.; de Lima Neto, P.; Junior, J. R.
C.; Costa-Lotufo, L. V.; Ferreira, E. G.; Tinoco, L. W.; Braz-Filho, R.;
Silveira, E. R.; Lima, M. A. S. J. Braz. Chem. Soc. 2015, 26, 1152.
(10) (a)Timberlake, J. W.; Alender, J.; Garner, A. W.; Hodges, M.
L.; Özmeral, C.; Szilagyi, S. J. Org. Chem. 1981, 46, 2082. (b) Hossain,
M. T.; Timberlake, J. W. J. Org. Chem. 2001, 66, 6282.
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
(20) Verotta, L.; Pilati, T.; Tatò, M.; Elisabetsky, E.; Amador, T.
A.; Nunes, D. S. J. Nat. Prod. 1998, 61, 392.
(21) (a) Libot, F.; Miet, C.; Kunesch, N.; Poisson, J. E.; Pusset, J.;
Sévenet, T. J. Nat. Prod. 1987, 50, 468. (b) Libot, F.; Kunesch, N.;
Poisson, J. Heterocycles 1988, 27, 2381.
(22) Guéritte-Voegelein, F.; Sévenet, T.; Pusset, J.; Adeline, M.-T.;
Gillet, B.; Beloeil, J.-C.; Guénard, D.; Potier, P.; Rasolonjanahary, R.;
Kordon, C. J. Nat. Prod. 1992, 55, 923.
(11) For representative examples, see: (a) Baldwin, J. E.; Adling-
ton, R. M.; Bottaro, J. C.; Kolhe, J. N.; Newington, I. M.; Perry, M. W.
D. Tetrahedron, 1986, 42, 4235. (b) Lim, Y.-K.; Lee, K.-S.; Cho, C.-G.
Org. Lett. 2003, 5, 979.
(12) 4-Methoxyphenyl hydrazine 18 decomposes immedi-
ately upon exposure to silver trifluoromethanesulfonate (2
equiv) in dichloromethane. Consistent with successful bromide
activation followed by undesired hydration, the C3a-
7
ACS Paragon Plus Environment